News

2021 Pipeline Insights into Scleroderma – Key Players Include Corbus Pharmaceuticals, Gesynta Pharma and Formation Biologics – ResearchAndMarkets.com

March 24, 2021

DUBLIN–(BUSINESS WIRE)–The “Scleroderma – Pipeline Insight, 2021” drug pipelines has been added to ResearchAndMarkets.com’s offering. This report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Scleroderma pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of…

Details

Sakara Life Announces Series B Fundraise and Appoints John Replogle As Chairman of the Board to Architect New CPG Category

March 24, 2021

NEW YORK–(BUSINESS WIRE)–Sakara Life, the direct-to-consumer New York City-based wellness and lifestyle program that is transforming lives by harnessing the power of food as medicine, announced today the completion of a $15 million Series B financing with significant investment from new investors One Better Ventures, Silas Capital (Boll & Branch, Herbivore, ILIA) and existing investor,…

Details

The Parent Company Launches Fun Uncle Cruisers – a Disruptive Entry Into the Value Vape Category

March 24, 2021

SAN JOSE, Calif.–(BUSINESS WIRE)–TPCO Holding Corp. (“The Parent Company”) (NEO: GRAM.U, GRAM.WT.U) (OTCQX: GRAMF; OTC PINK: GRMWF) house of brands, extends its product offerings today with the launch of Fun Uncle Cruisers, full gram vape cartridges available in five popular strains for just $25. The launch of Cruisers delivers on The Parent Company’s promise of…

Details

Traditional Medicinals’ Herbalists Offer Tips to Step Into Spring

March 24, 2021

SEBASTOPOL, Calif.–(BUSINESS WIRE)–Traditional Medicinals, pioneer of the wellness tea category, is reminding people that as the seasons change, it is important to continue to take care of ourselves and each other with plant and herbal education. For more than 40 years, Traditional Medicinals has ethically sourced high-quality herbs and ingredients to create over 50 carefully…

Details

Altria Group, Inc. Director and Chairman of the Board of Directors Thomas F. Farrell II Announces Decision to Retire From Altria’s Board of Directors

March 23, 2021

RICHMOND, Va.–(BUSINESS WIRE)–Thomas F. Farrell II, a director of Altria Group, Inc. (“Altria”) since 2008 and independent Chairman of Altria’s Board of Directors (the “Board”), notified Altria of his decision to retire from service on the Board following the completion of his current term. Consequently, Mr. Farrell will not stand for re-election to the Board…

Details

Turning Point Brands Appoints Louie Reformina as Chief Financial Officer

March 23, 2021

LOUISVILLE, Ky.–(BUSINESS WIRE)–Turning Point Brands, Inc. (“TPB” or the “Company”) (NYSE: TPB), a manufacturer, marketer and distributor of branded consumer products, including alternative smoking accessories and consumables with active ingredients, announced today that Louie Reformina, Turning Point Brands’ current Chief Business Development Officer, will be appointed the Company’s new Chief Financial Officer, effective May 1,…

Details

Schwazze to Host Fourth Quarter 2020 Conference Call and Webcast on March 30, 2021

March 23, 2021

DENVER–(BUSINESS WIRE)–Schwazze, formerly operating as Medicine Man Technologies Inc. (OTCQX: SHWZ) (“Schwazze ” or “the Company”), today announced that it will host its fourth quarter 2020 conference call and webcast on Tuesday, March 30, 2021 at 4:30 p.m. ET. Investors interested in participating in the conference call can dial 201-389-0879 or listen to the webcast…

Details

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Neptune Wellness Solutions Inc. (NEPT)

March 23, 2021

LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming May 17, 2021 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Neptune Wellness Solutions Inc. (“Neptune” or the “Company”) (NASDAQ: NEPT) securities between July 24, 2019 and February 16,…

Details

POSaBIT and Olla Partner on POS and Menu Integration for Dispensaries

March 23, 2021

SEATTLE–(BUSINESS WIRE)–POSaBIT Systems Corporation (CSE: PBIT), a leading financial technology company with an industry-leading cannabis point of sale system and unique payment processing solutions for cash-only businesses with a focus on those within the cannabis industry, has officially partnered with Olla, a next-gen eCommerce platform for cannabis retailers. The partnership features a full integration of…

Details

HempFusion Wellness Announces Toxicology Results from Validcare’s Clinical Study on CBD Liver Safety

March 23, 2021

DENVER, Colo.–(BUSINESS WIRE)–HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness company offering premium probiotic supplements and products containing CBD, is pleased to announce that Validcare, the organization coordinating the execution of what the Company believes to be the largest human observational, liver and human toxicology study to date,…

Details

A88CBD™ Products Now Available in Gabe’s, Reasor’s Foods and Banner Wholesale Grocers

March 23, 2021

SCOTTSDALE, Ariz.–(BUSINESS WIRE)–The Alkaline Water Company Inc. (NASDAQ and CSE: WTER) (the “Company”), premium producer of bottled alkaline water and CBD infused products, is pleased to announce new partnerships with three retailers — Gabe’s, Reasor’s Foods and Banner Wholesale Grocers — to carry its A88CBD™ and A88 Infused™ products. Specialty discount retailer Gabe’s will carry…

Details

CURE Pharmaceutical Augments Its Existing U.S. DEA License in Order to Initiate Development of Its Psychedelics-Based Pharmaceutical Clinical Pipeline

March 23, 2021

OXNARD, Calif.–(BUSINESS WIRE)–CURE Pharmaceutical Holding Corp. (“CURE” or the “Company”) (OTC: CURR), a vertically integrated drug delivery and product development company, announced today that it has secured an extension to its Schedule I U.S. Drug Enforcement Agency (DEA) license that will allow the Company to conduct research on psychedelics-based pharmaceuticals using compounds such as LSD,…

Details